Search - tctmd.com

Displaying 141 - 160 of 164

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the PARTNER Aortic Valve-in-Valve Registry

Presenter: Vinayak Bapat, Ran Kornowski, Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Direct Aortic TAVR Balloon Burst and Stuck! A Creative Way to Retrieve It

Presenter: Ashish Pershad, Tilak Pasala, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Presenter: Hüseyin Ince

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Vinayak Bapat, Ran Kornowski, Danny Dvir

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Presenter: Anita Asgar

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

Video

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

June 26, 2018

Video

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

June 26, 2018

Video

SHDS 2018: Point: A Minimalist Strategy Should be Used in ALL TAVR Patients!

July 4, 2018

Video

SHDS 2018: Perspectives From the NEW Multi-society (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

June 26, 2018

Video

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

June 26, 2018

Video

» Live Case

SHDS 2018: Live Cases #9: University of Washington Medical Center/Regional Heart Center, Seattle, WA - TAVR

June 26, 2018

Video

» Live Case

SHDS 2018: Live Case #6: St. Paul’s Hospital, Vancouver, Canada - TAVR

June 26, 2018

Video

» Live Case

SHDS 2018: Live Case #5: Cedars-Sinai Medical Center, Los Angeles, CA - TAVR

June 26, 2018

Video

» Live Case

SHDS 2018: Live Case #4: St. Paul’s Hospital, Vancouver, Canada - TAVR

June 26, 2018

Advertisement

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Ulm University (Germany)

Updates from the PARTNER Aortic Valve-in-Valve Registry

Direct Aortic TAVR Balloon Burst and Stuck! A Creative Way to Retrieve It

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

SHDS 2018: Point: A Minimalist Strategy Should be Used in ALL TAVR Patients!

SHDS 2018: Perspectives From the NEW Multi-society (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

SHDS 2018: Live Cases #9: University of Washington Medical Center/Regional Heart Center, Seattle, WA - TAVR

SHDS 2018: Live Case #6: St. Paul’s Hospital, Vancouver, Canada - TAVR

SHDS 2018: Live Case #5: Cedars-Sinai Medical Center, Los Angeles, CA - TAVR

SHDS 2018: Live Case #4: St. Paul’s Hospital, Vancouver, Canada - TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content